Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
TO PROVIDE MONITORING SERVICES FOR ONE (1) PHASE III CLINICAL TRIAL, A5300B/PHOENIXDepartment of Health and Human Services$5.7M obligationsEnds Dec 14, 2025
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMSDepartment of Health and Human Services$0 obligationsEnds Aug 31, 2022
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)Department of Health and Human Services$21.9M obligationsEnds Oct 31, 2021
TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTERDepartment of Health and Human Services$27.0M obligationsEnds Aug 20, 2026
ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUING SUPPORT FOR COVID-19 VACCINE…Department of Health and Human Services$126.5M obligationsEnds Sep 28, 2029
TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CTDepartment of Health and Human Services$2.0M obligationsEnds Apr 28, 2027
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)Department of Health and Human Services$26.1M obligationsEnds Aug 14, 2027
BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.Department of Health and Human Services$1.3M obligationsEnds Nov 22, 2027
REGULATORY MANAGEMENT CENTER (RMC)Department of Health and Human Services$17.4M obligationsEnds Oct 31, 2026
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)Department of Health and Human Services$36.4M obligationsEnds Jun 29, 2027
TBTC MONITORINGDepartment of Health and Human Services$2.1M obligationsEnds Jun 27, 2024
REGULATORY CONSULTING ASSISTANCE FOR MEDICAL DEVICE DEVELOPER. RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. TASK ORDER 02. 09/15/2023 - 09/14/2024.Department of Health and Human Services$63.6K obligationsEnds Dec 31, 2024
FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASUREDepartment of Health and Human Services$724.5K obligationsEnds Jul 15, 2027
NIAID CLINICAL SITE MONITORING (NCSM)Department of Health and Human Services$73.2M obligationsEnds Jan 31, 2027
TASK ORDER 75N93022F00001 BASE AWARDDepartment of Health and Human Services$905.5K obligationsEnds Jan 13, 2027
ACQUISITION TITLE: CLINICAL SITE AND STUDY MONITORING SUPPORT SERVICES FOR THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE'S HYPERTENSION OUTCOMES FOR T4 RESEARCH WITHIN LOWER…Department of Health and Human Services$654.6K obligationsEnds Jul 25, 2023
RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029. BASE AND EXERCISE 2 UNITS OF…Department of Health and Human Services$324.4K obligationsEnds Jun 16, 2029
DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)Department of Health and Human Services$3.1M obligationsEnds Dec 14, 2026
EPCTUDepartment of Health and Human Services$2.8M obligationsEnds Jan 31, 2026
BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC…Department of Health and Human Services$117.4M obligationsEnds Sep 30, 2030
BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL…Department of Health and Human Services$1.8M obligationsEnds Mar 10, 2025
IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)Department of Health and Human Services$329.8M obligationsEnds Aug 14, 2024
COVID 19. THIS TASK ORDER IS TO PROVIDE COMPREHENSIVE/FULL CLINICAL TRIAL MANAGEMENT SUPPORT SERVICES TO THE ONGOING ACTIV-2 CLINICAL TRIAL. THE CONTRACTOR SHALL COMPLY WITH…Department of Health and Human Services$34.6M obligationsEnds Nov 5, 2022
IGF::OT::IGF NIAID CLINICAL SITE MONITORINGDepartment of Health and Human Services$135.1M obligationsEnds Jan 31, 2024
CLINICAL RESEARCH AND STUDY MONITORING SUPPORT FOR NIMH STUDIESDepartment of Health and Human Services$1.2M obligationsEnds May 15, 2025